The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study

dc.contributor.author	Ueda, Peter
dc.contributor.author	Wintzell, Viktor
dc.contributor.author	Dahlqwist, Elisabeth
dc.contributor.author	Eliasson, Björn
dc.contributor.author	Svensson, Ann-Marie
dc.contributor.author	Franzén, Stefan
dc.contributor.author	Gudbjörnsdottir, Soffia
dc.contributor.author	Hveem, Kristian
dc.contributor.author	Jonasson, Christian
dc.contributor.author	Melbye, Mads
dc.contributor.author	Hviid, Anders
dc.contributor.author	Svanström, Henrik
dc.contributor.author	Pasternak, Björn
dc.date.accessioned	2022-05-30T06:14:21Z
dc.date.available	2022-05-30T06:14:21Z
dc.date.created	2021-12-02T14:08:54Z
dc.date.issued	2021
dc.identifier.citation	Diabetes, obesity and metabolism. 2021, 1-13.
dc.identifier.issn	1462-8902
dc.identifier.uri	https://hdl.handle.net/11250/2996577
dc.language.iso	eng
dc.title	The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.description.version	publishedVersion
dc.source.pagenumber	1-13
dc.source.journal	Diabetes, obesity and metabolism
dc.identifier.doi	10.1111/dom.14598
dc.identifier.cristin	1963490
cristin.ispublished	true
cristin.fulltext	original
cristin.fulltext	original
cristin.qualitycode	1